- Home
- CYRX vs PSNL Comparison
CYRX vs PSNL Comparison
Compare CYRX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- PSNL
- Stock Information
- Founded
- CYRX 1999
- PSNL 2011
- Country
- CYRX United States
- PSNL United States
- Employees
- CYRX N/A
- PSNL N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- PSNL Medical Specialities
- Sector
- CYRX Health Care
- PSNL Health Care
- Exchange
- CYRX Nasdaq
- PSNL Nasdaq
- Market Cap
- CYRX 438.7M
- PSNL 854.8M
- IPO Year
- CYRX N/A
- PSNL 2019
- Fundamental
- Price
- CYRX $9.24
- PSNL $9.64
- Analyst Decision
- CYRX Strong Buy
- PSNL Strong Buy
- Analyst Count
- CYRX 9
- PSNL 5
- Target Price
- CYRX $12.56
- PSNL $8.70
- AVG Volume (30 Days)
- CYRX 762.8K
- PSNL 1.3M
- Earning Date
- CYRX 11-04-2025
- PSNL 11-04-2025
- Dividend Yield
- CYRX N/A
- PSNL N/A
- EPS Growth
- CYRX N/A
- PSNL N/A
- EPS
- CYRX 1.35
- PSNL N/A
- Revenue
- CYRX $237,879,000.00
- PSNL $80,317,000.00
- Revenue This Year
- CYRX N/A
- PSNL N/A
- Revenue Next Year
- CYRX $9.20
- PSNL $29.83
- P/E Ratio
- CYRX $6.87
- PSNL N/A
- Revenue Growth
- CYRX 24.93
- PSNL 0.36
- 52 Week Low
- CYRX $4.58
- PSNL $2.83
- 52 Week High
- CYRX $11.44
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- CYRX 45.23
- PSNL 62.73
- Support Level
- CYRX $8.95
- PSNL $9.40
- Resistance Level
- CYRX $11.11
- PSNL $10.06
- Average True Range (ATR)
- CYRX 0.73
- PSNL 0.88
- MACD
- CYRX -0.17
- PSNL -0.07
- Stochastic Oscillator
- CYRX 13.88
- PSNL 58.68
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.